Investor Relations Captor Therapeutics ®
Candidate for Member of the Supervisory Board of the Company
Publication date:
Publication time:
Current Report No. 28/2026
Date of preparation: 10 June 2026
Subject: Candidate for Member of the Supervisory Board of the Company
Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (“the Company”), with reference to current report No. 27/2026 of 8 June 2026 regarding the nomination of Mr Andrew Galazka as a member of the Company’s Supervisory Board, hereby announces that on it received from the Company's shareholder – the PZU “Złota Jesień” Open Pension Fund, represented by Powszechne Towarzystwo Emerytalne PZU S.A. – an updated professional CV of the candidate.
The Company attaches the submitted CV to this report.